<DOC>
	<DOCNO>NCT02829346</DOCNO>
	<brief_summary>This study evaluate peri-articular tranexamic acid injection total knee arthroplasty alternative route administration blood loss reduction . Half participant receive intravenous tranexamic acid injection , half receive peri-articular tranexamic acid injection total knee arthroplasty .</brief_summary>
	<brief_title>Peri-articular Tranexamic Acid Injection Total Knee Arthroplasty</brief_title>
	<detailed_description>Intravenous tranexamic acid ( IV TXA ) one effective agent use reduce blood loss follow total knee arthroplasty ( TKA ) safety regard venous thromboembolic event ( VTEs ) remain question . The direct , local application TXA may reduce systemic toxicity whilst maintain good well bleed control compare IV TXA . The topical application TXA via Hemovac drain report previously good result . However , data peri-articular TXA injection TKA .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>adult patient osteoarthritis need TKA inflammatory arthritis posttraumatic arthritis history current venous thromboembolic disease underlie disease haemostasis cirrhosis chronic renal failure patient anticoagulant strong antiplatelet drug ( e.g . warfarin , clopidogrel ) know allergy TXA defective color vision preoperative hemoglobin &lt; 10 g/dL platelet count &lt; 140,000 /uL3</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Tranexamic acid</keyword>
	<keyword>Peri-articular injection</keyword>
	<keyword>Total knee arthroplasty</keyword>
	<keyword>Blood loss</keyword>
	<keyword>Osteoarthritis , Knee</keyword>
</DOC>